Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Laboratory Corp American Holdings
(NY:
LH
)
305.51
-6.03 (-1.93%)
Streaming Delayed Price
Updated: 12:41 PM EDT, Sep 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Laboratory Corp American Holdings
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect
February 17, 2025
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting results tomorrow morning. Here’s what to look for.
Via
StockStory
Labcorp Q4 Earnings: Revenue And EPS Beat, Expects Strong 2025 Growth, Analyst Reiterates Outperform On Stable 2025 Outlook
↗
February 06, 2025
Labcorp's Q4 EPS of $3.45 topped estimates, with sales rising 9.8% to $3.33 billion. 2025 guidance points to continued growth in diagnostics and biopharma.
Via
Benzinga
Labcorp (NYSE:LH) Surprises With Q4 Sales, Full-Year Outlook Slightly Exceeds Expectations
February 06, 2025
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 9.8% year on year to $3.33 billion. The company’s full-year revenue...
Via
StockStory
Earnings Scheduled For February 6, 2025
↗
February 06, 2025
Via
Benzinga
Labcorp (LH) Reports Earnings Tomorrow: What To Expect
February 05, 2025
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be reporting earnings tomorrow before the bell. Here’s what to look for.
Via
StockStory
Beyond The Numbers: 6 Analysts Discuss Labcorp Holdings Stock
↗
February 03, 2025
Via
Benzinga
Beyond The Numbers: 8 Analysts Discuss Labcorp Holdings Stock
↗
January 07, 2025
Via
Benzinga
Analyst Expectations For Labcorp Holdings's Future
↗
December 10, 2024
Via
Benzinga
Jim Cramer Says Lazard Is 'Really Inexpensive,' Recommends Buying This Tech Stock
↗
January 03, 2025
Via
Benzinga
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
↗
November 09, 2024
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization.
Via
Benzinga
Topics
Government
Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience
November 04, 2024
From
Praia Health
Via
Business Wire
Expert Outlook: Labcorp Holdings Through The Eyes Of 12 Analysts
↗
October 25, 2024
Via
Benzinga
Analyst Ratings For Labcorp Holdings
↗
September 20, 2024
Via
Benzinga
Analyst Expectations For Labcorp Holdings's Future
↗
August 05, 2024
Via
Benzinga
LabCorp Analysts Boost Their Forecasts After Better-Than-Expected Earnings
↗
August 02, 2024
Via
Benzinga
Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact
↗
October 24, 2024
LabCorp Q3 2024 EPS beats expectations at $3.50, with 7.4% revenue growth to $3.28B. Adjusted EPS guidance revised due to weather.
Via
Benzinga
Topics
Earnings
UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday
↗
October 24, 2024
Via
Benzinga
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
October 16, 2024
From
NOWDiagnostics, Inc.
Via
Business Wire
Labcorp Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
↗
July 08, 2024
Via
Benzinga
Forecasting The Future: 4 Analyst Projections For Labcorp Holdings
↗
May 30, 2024
Via
Benzinga
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
↗
August 26, 2024
Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Quest Diagnostics are also monitoring demand and expanding testing...
Via
Benzinga
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
↗
August 04, 2024
Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, DexCom, Sprouts Farmers Market, UL Solutions, Labcorp Holdings, C.H....
Via
Benzinga
LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector
↗
August 01, 2024
LabCorp reported Q2 2024 adjusted EPS of $3.94, surpassing expectations of $3.78. Sales increased by 6.2% to $3.22 billion, driven by organic revenue growth and acquisitions. LabCorp revised its 2024...
Via
Benzinga
Is This Telehealth Stock a Buy After the Recent Pullback?
July 19, 2024
Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions.
Via
MarketBeat
Analyst Ratings For Laboratory Corp
↗
April 26, 2024
Via
Benzinga
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
April 30, 2024
Via
AB Newswire
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
↗
April 25, 2024
Intelligent Bio Solutions (Nasdaq: INBS) is a medical technology company developing and commercializing innovative, intelligent, rapid, noninvasive testing solutions.
Via
Talk Markets
Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal
↗
April 25, 2024
Labcorp beats Q1 sales estimates, driven by organic growth and acquisitions. Revised 2024 guidance projects higher EPS and sales growth. The acquisition of Invitae is expected to bolster Labcorp's...
Via
Benzinga
LH Stock Earnings: Laboratory Corp Beats EPS, Beats Revenue for Q1 2024
↗
April 25, 2024
LH stock results show that Laboratory Corp beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp
April 01, 2024
From
Xcell Biosciences Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today